Moreover, the analysis of an TMA consisting of 453 consecutive RCC tumors revealed a weak, but significant correlation of CREB1 with tumor stage, tumor grade TNM V and TNM L. To further validate the results of this study, the analyses of additional cohorts could be of interest. This evidence concerns the gene CREB1 and renal cell carcinoma.